Johnson & Johnson-backed medical technology producer NeuroPace has added $74m in funding in a round co-led by Orbimed and KCK Group.
NeuroPace, a US-based, epilepsy-focused medical device manufacturer backed by pharmaceutical firm Johnson & Johnson, raised $74m on Tuesday in a round co-led by investment firms KCK Group and Orbimed Advisors.
Founded in 1997, NeuroPace has developed an implantable, neurostimulation system that reduces the frequency of seizures. Some 3.4 million Americans suffer from epilepsy, according to health protection agency Centers for Disease Control and Prevention (CDC)
The device, NeuroPace RNS, has received regulatory approval in the US for patients suffering from…
